These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35571490)

  • 21. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Wang H; Xu B; Shi J
    Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m
    Wang K; Jiang L; Zhang Y; Chen C
    Onco Targets Ther; 2020; 13():1605-1612. PubMed ID: 32158230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
    Dong G; Yu J; Shan G; Su L; Yu N; Yang S
    Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
    Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
    Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
    [No Abstract]   [Full Text] [Related]  

  • 28. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MTTL3 upregulates microRNA-1246 to promote occurrence and progression of NSCLC via targeting paternally expressed gene 3.
    Huang S; Luo S; Gong C; Liang L; Xiao Y; Li M; He J
    Mol Ther Nucleic Acids; 2021 Jun; 24():542-553. PubMed ID: 33898106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.
    Shen S; Yan J; Zhang Y; Dong Z; Xing J; He Y
    Ann Transl Med; 2021 Jan; 9(1):59. PubMed ID: 33553352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.
    Xiang S; Liang X; Yin S; Liu J; Xiang Z
    Am J Transl Res; 2020; 12(5):1789-1806. PubMed ID: 32509177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma.
    Wang J; Wang W; Huang X; Cao J; Hou S; Ni X; Peng C; Liu T
    J Bone Oncol; 2022 Feb; 32():100411. PubMed ID: 35145841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.
    Yuan Y; Du Y; Wang L; Liu X
    J Cancer; 2020; 11(12):3588-3595. PubMed ID: 32284755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma.
    Zhao L; Ma H; Jiang Y; Li Y; Guo N; Chen Y; Jiang X; Zhao Y; Yang J; Liu Y; Wen K; Wang L; Jian L; Fan X
    Phytomedicine; 2024 Dec; 135():156002. PubMed ID: 39326134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms.
    Wang X; Zhang Q; Wang Y; Zhuang H; Chen B
    Med Sci Monit; 2018 Mar; 24():1742-1750. PubMed ID: 29574466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma.
    Xu RY; Ding Z; Zhao Q; Ke TY; Chen S; Wang XY; Wang YY; Sheng MF; Wang W; Long N; Shen YX; Xu YZ; Shao W
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N(6)-methyladenosine RNA methyltransferase like 3 inhibits extracellular matrix synthesis of endplate chondrocytes by downregulating sex-determining region Y-Box transcription factor 9 expression under tension.
    Xiao L; Hu B; Ding B; Zhao Q; Liu C; Öner FC; Xu H
    Osteoarthritis Cartilage; 2022 Apr; 30(4):613-625. PubMed ID: 35007741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
    Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
    Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia.
    Gu Y; Chu X; Morgan JA; Lewis DF; Wang Y
    Placenta; 2021 Jan; 103():43-49. PubMed ID: 33070036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.